Cargando…
BMP and TGFβ use and release in bone regeneration
A fracture that does not unite in nine months is defined as nonunion. Nonunion is common in fragmented fractures and large bone defects where vascularization is impaired. The distal third of the tibia, the scaphoid bone or the talus fractures are furthermore prone to nonunion. Open fractures and spi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672355/ https://www.ncbi.nlm.nih.gov/pubmed/32336073 http://dx.doi.org/10.3906/sag-2003-127 |
_version_ | 1783611116499238912 |
---|---|
author | BAL, Zeynep KUSHIOKA, Junichi KODAMA, Joe KAITO, Takashi YOSHIKAWA, Hideki KORKUSUZ, Petek KORKUSUZ, Feza |
author_facet | BAL, Zeynep KUSHIOKA, Junichi KODAMA, Joe KAITO, Takashi YOSHIKAWA, Hideki KORKUSUZ, Petek KORKUSUZ, Feza |
author_sort | BAL, Zeynep |
collection | PubMed |
description | A fracture that does not unite in nine months is defined as nonunion. Nonunion is common in fragmented fractures and large bone defects where vascularization is impaired. The distal third of the tibia, the scaphoid bone or the talus fractures are furthermore prone to nonunion. Open fractures and spinal fusion cases also need special monitoring for healing. Bone tissue regeneration can be attained by autografts, allografts, xenografts and synthetic materials, however their limited availability and the increased surgical time as well as the donor site morbidity of autograft use, and lower probability of success, increased costs and disease transmission and immunological reaction probability of allografts oblige us to find better solutions and new grafts to overcome the cons. A proper biomaterial for regeneration should be osteoinductive, osteoconductive, biocompatible and mechanically suitable. Cytokine therapy, where growth factors are introduced either exogenously or triggered endogenously, is one of the commonly used method in bone tissue engineering. Transforming growth factor β (TGFβ) superfamily, which can be divided structurally into two groups as bone morphogenetic proteins (BMPs), growth differentiation factors (GDFs) and TGFβ, activin, Nodal branch, Mullerian hormone, are known to be produced by osteoblasts and other bone cells and present already in bone matrix abundantly, to take roles in bone homeostasis. BMP family, as the biggest subfamily of TGFβ superfamily, is also reported to be the most effective growth factors in bone and development, which makes them one of the most popular cytokines used in bone regeneration. Complications depending on the excess use of growth factors, and pleiotropic functions of BMPs are however the main reasons of why they should be approached with care. In this review, the Smad dependent signaling pathways of TGFβ and BMP families and their relations and the applications in preclinical and clinical studies will be briefly summarized. |
format | Online Article Text |
id | pubmed-7672355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Scientific and Technological Research Council of Turkey |
record_format | MEDLINE/PubMed |
spelling | pubmed-76723552021-09-28 BMP and TGFβ use and release in bone regeneration BAL, Zeynep KUSHIOKA, Junichi KODAMA, Joe KAITO, Takashi YOSHIKAWA, Hideki KORKUSUZ, Petek KORKUSUZ, Feza Turk J Med Sci Article A fracture that does not unite in nine months is defined as nonunion. Nonunion is common in fragmented fractures and large bone defects where vascularization is impaired. The distal third of the tibia, the scaphoid bone or the talus fractures are furthermore prone to nonunion. Open fractures and spinal fusion cases also need special monitoring for healing. Bone tissue regeneration can be attained by autografts, allografts, xenografts and synthetic materials, however their limited availability and the increased surgical time as well as the donor site morbidity of autograft use, and lower probability of success, increased costs and disease transmission and immunological reaction probability of allografts oblige us to find better solutions and new grafts to overcome the cons. A proper biomaterial for regeneration should be osteoinductive, osteoconductive, biocompatible and mechanically suitable. Cytokine therapy, where growth factors are introduced either exogenously or triggered endogenously, is one of the commonly used method in bone tissue engineering. Transforming growth factor β (TGFβ) superfamily, which can be divided structurally into two groups as bone morphogenetic proteins (BMPs), growth differentiation factors (GDFs) and TGFβ, activin, Nodal branch, Mullerian hormone, are known to be produced by osteoblasts and other bone cells and present already in bone matrix abundantly, to take roles in bone homeostasis. BMP family, as the biggest subfamily of TGFβ superfamily, is also reported to be the most effective growth factors in bone and development, which makes them one of the most popular cytokines used in bone regeneration. Complications depending on the excess use of growth factors, and pleiotropic functions of BMPs are however the main reasons of why they should be approached with care. In this review, the Smad dependent signaling pathways of TGFβ and BMP families and their relations and the applications in preclinical and clinical studies will be briefly summarized. The Scientific and Technological Research Council of Turkey 2020-11-03 /pmc/articles/PMC7672355/ /pubmed/32336073 http://dx.doi.org/10.3906/sag-2003-127 Text en Copyright © 2020 The Author(s) This article is distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Article BAL, Zeynep KUSHIOKA, Junichi KODAMA, Joe KAITO, Takashi YOSHIKAWA, Hideki KORKUSUZ, Petek KORKUSUZ, Feza BMP and TGFβ use and release in bone regeneration |
title | BMP and TGFβ use and release in bone regeneration |
title_full | BMP and TGFβ use and release in bone regeneration |
title_fullStr | BMP and TGFβ use and release in bone regeneration |
title_full_unstemmed | BMP and TGFβ use and release in bone regeneration |
title_short | BMP and TGFβ use and release in bone regeneration |
title_sort | bmp and tgfβ use and release in bone regeneration |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672355/ https://www.ncbi.nlm.nih.gov/pubmed/32336073 http://dx.doi.org/10.3906/sag-2003-127 |
work_keys_str_mv | AT balzeynep bmpandtgfbuseandreleaseinboneregeneration AT kushiokajunichi bmpandtgfbuseandreleaseinboneregeneration AT kodamajoe bmpandtgfbuseandreleaseinboneregeneration AT kaitotakashi bmpandtgfbuseandreleaseinboneregeneration AT yoshikawahideki bmpandtgfbuseandreleaseinboneregeneration AT korkusuzpetek bmpandtgfbuseandreleaseinboneregeneration AT korkusuzfeza bmpandtgfbuseandreleaseinboneregeneration |